Cargando…

Safety Evaluation of the Omnipod® 5 Automated Insulin Delivery System Over Three Months of Use in Children With Type 1 Diabetes (T1D)

Advances in diabetes technology have transformed the treatment paradigm for T1D, yet the burden of the disease remains significant. The pediatric population poses unique challenges to glucose management with unpredictable exercise and food consumption. The Omnipod 5 System is a novel hybrid closed-l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buckingham, Bruce A, Forlenza, Gregory P, Criego, Amy B, Hansen, David W, Bode, Bruce W, Brown, Sue A, MacLeish, Sarah A, Pinsker, Jordan E, DeSalvo, Daniel J, Sherr, Jennifer L, Mehta, Sanjeev N, Laffel, Lori M, Bhargava, Anuj, Ly, Trang T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Diabetes Mellitus and Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090047/ http://dx.doi.org/10.1210/jendso/bvab048.927

Ejemplares similares

The Use of Omnipod® 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes With Suboptimal Glycemic Management: From Injections to Closed-Loop Therapy
por: Bode, Bruce W, et al.
Publicado: (2021)

Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
por: Brown, Sue A., et al.
Publicado: (2021)

Clinical Implementation of the Omnipod 5 Automated Insulin Delivery System: Key Considerations for Training and Onboarding People With Diabetes
por: Berget, Cari, et al.
Publicado: (2022)

Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm
por: Buckingham, Bruce A., et al.
Publicado: (2018)

Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes
por: Buckingham, Bruce A., et al.
Publicado: (2018)

Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 Diabetes
por: Forlenza, Gregory P., et al.
Publicado: (2019)

Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions
por: Sherr, Jennifer L., et al.
Publicado: (2020)

Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical Trial
por: Sherr, Jennifer L., et al.
Publicado: (2022)

Swimming With the Omnipod 5 Automated Insulin Delivery System: Connectivity in the Water
por: Hughes, Michael S., et al.
Publicado: (2023)

Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy
por: Davis, Georgia M., et al.
Publicado: (2023)

SAT-641 Self-Reported Psychological Stress and Glucose Variability in Type 1 Diabetes on Sensor Augmented Pump over 5 Weeks
por: Kaur, Ravinder Jeet, et al.
Publicado: (2020)

PSUN267 New-Onset Type 1 Diabetes (T1D) In a Child Presenting With Diabetic Ketoacidosis (DKA) and Severe Hypertriglyceridemia Without Pancreatitis
por: Vitale, Rebecca, et al.
Publicado: (2022)

SAT-671 Glycogenic Hepatopathy. A Rare and Dramatic Manifestation of Poorly Controlled Type 1 Diabetes
por: Maciel, Cassie, et al.
Publicado: (2020)

SUN-184 Sertraline-Induced Hypoglycemia in Nondiabetic Patients
por: Bhargava, Pooja, et al.
Publicado: (2019)

SAT-LB027 Does Diabetes Education Influence Glycosylated Hemoglobin?
por: Bhargava, Pooja, et al.
Publicado: (2019)

OR14-4 Early Glomerular Hyperfiltration and Long Term Kidney Outcomes in Type 1 Diabetes: The DCCT/EDIC Experience
por: Molitch, Mark, et al.
Publicado: (2019)

SUN-LB030 Empagliflozin Causing Euglycemic Diabetic Ketoacidosis
por: Thomas, Mathew, et al.
Publicado: (2019)

Effect of Lipohypertrophy on Accuracy of Continuous Glucose Monitoring in Patients With Type 1 Diabetes
por: DeSalvo, Daniel J., et al.
Publicado: (2015)

SAT-653 Exploring the Role of Brown Adipokines on Hepatic Insulin Resistance Using a Microfluidic Organ-On-Chip
por: Tanataweethum, Nida, et al.
Publicado: (2020)

Employing User-Centered Design and Learning Science Theory to Enhance Remote Delivery of Diabetes Education and Survival Skills at Hospital Discharge
por: Prince, Grace, et al.
Publicado: (2021)

SAT-121 Immediate Dysglycemia After Pancreatic Resection: Prevalence and Risk Factors
por: Enke, Thomas, et al.
Publicado: (2019)

SAT-635 Results of a Preclinical Pilot Study Evaluating 24-Hour Subcutaneous Infusion of the GLP-1 Analogue Liraglutide Delivered via the H-Patch Wearable Device
por: Barnes, Jessica W, et al.
Publicado: (2020)

SAT-175 (-)-Epicatechin Modulates Cellular Signaling and Mitochondrial Redox in Endothelium
por: Johnston, Aspen, et al.
Publicado: (2019)

Identification of Sortilin Alternatively Spliced Variants in 3T3L1 Adipocytes
por: Lui, Ashley, et al.
Publicado: (2021)

MON-631 Quality of Life in a Pragmatic Trial of a Type 1 Diabetes Adolescent Transition Program
por: Leung, Joseph M W S, et al.
Publicado: (2020)

SUN-629 Text for Success in Gestational Diabetes: Development and User Experience Testing of a Text Messaging Program
por: Blair, Rachel A, et al.
Publicado: (2020)

Do GLP-1 Receptor Agonists Increase the Risk of Breast Cancer? A Systematic Review and Meta-Analysis
por: Piccoli, Giovana Fagundes, et al.
Publicado: (2021)

Improved Glycemic Control Following Transition to Tubeless Insulin Pump Therapy in Adults With Type 1 Diabetes
por: Mehta, Sanjeev N., et al.
Publicado: (2021)

OR08-03 Association of Hemoglobin A1c with Early Postpartum Metabolic Syndrome in Women with Gestational Diabetes
por: Blair, Rachel A, et al.
Publicado: (2020)

Efficacy of Dulaglutide Expanded Doses by Baseline A1C Categories: Post Hoc Analysis of AWARD-11
por: Frias, Juan Pablo, et al.
Publicado: (2021)

SAT-674 Anti PD1 Induced Type 1 Diabetes
por: Naranjo, Maria Belen, et al.
Publicado: (2020)

SAT-150 Forkhead Box Protein O1 (foxo1) Regulates Hepatic Serine Protease Inhibitor B1 (serpinb1) Expression In A Cell Non-autonomous Fashion
por: El Ouaamari, Abdelfattah, et al.
Publicado: (2019)

SUN-128 Novel Mutation in the HNF1A Gene in Siblings Previously Diagnosed with Type 1 Diabetes
por: Raisingani, Manish, et al.
Publicado: (2019)

SAT-630 Nutritional Influences on One Carbon Metabolism Exacerbate Diabetic Cardiomyopathy and Nephropathy
por: Al-Humadi, Ahmed W, et al.
Publicado: (2020)

MON-646 Novel Use of GLP-1 Receptor Agonist Therapy in MODY-1 (HNF4A Mutation)
por: Broome, David Tyler, et al.
Publicado: (2020)

SAT-680 Diabetes Mellitus Induced by Programmed Cell Death-1 (PD-1) Inhibitors: A Case Report
por: Abuaisha, Munder, et al.
Publicado: (2020)

MON-625 Utility of Continuous Glucose Monitoring in Children with Type 1 Diabetes: Is HbA1c Enough?
por: Owens, Lindsey L, et al.
Publicado: (2020)

Young Adult LEW.1WR1 Rats Develop Dysregulated Islet Function and Impaired Liver Insulin Responses
por: Wilkerson-Vidal, Quiana C, et al.
Publicado: (2021)

OR14-3 The Association of Glycemic Control and Glycemic Variability with Treatment Patterns and Diabetes-Related Events in the Adult Patients (Pts) with Type 1 Diabetes (T1D): Results from the T1D Exchange Clinic Registry
por: Wysham, Carol, et al.
Publicado: (2019)

The Use of Cultural Competency in Decreasing Diabetes Outcomes Disparities in a Community Health Care Setting
por: Toth, David W, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jpdmqhfev6prvr28it8pjg4112